tiprankstipranks
Peptidream Inc. (JP:4587)
:4587
Japanese Market
4587
Peptidream
RESEARCH TOOLSreports
Want to see JP:4587 full AI Analyst Report?

Peptidream (4587) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

4587 Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Peptidream
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

4587 Stock 12 Month Forecast

There Are No Analyst Ratings for JP:4587 In The Last 3 Months.
Highest Price Target―Average Price Target―Lowest Price Target―
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

4587 Financial Forecast

4587 Earnings Forecast

Next quarter’s earnings estimate for 4587 is -¥3.19 with a range of -¥3.19 to -¥3.19. The previous quarter’s EPS was -¥6.62. 4587 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year 4587 has Performed in-line its overall industry.
Next quarter’s earnings estimate for 4587 is -¥3.19 with a range of -¥3.19 to -¥3.19. The previous quarter’s EPS was -¥6.62. 4587 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year 4587 has Performed in-line its overall industry.

4587 Sales Forecast

Next quarter’s sales forecast for 4587 is ¥5.68B with a range of ¥5.68B to ¥5.68B. The previous quarter’s sales results were ¥4.76B. 4587 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year 4587 has Performed in-line its overall industry.
Next quarter’s sales forecast for 4587 is ¥5.68B with a range of ¥5.68B to ¥5.68B. The previous quarter’s sales results were ¥4.76B. 4587 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year 4587 has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Citi Analyst forecast on JP:4587
Hidemaru Yamaguchi
Citi
Citi
¥1,600
Hold
-4.13%
Downside
Downgraded
03/12/26
Citi Remains a Hold on Peptidream (PPTDF)
SBI Securities Analyst forecast on JP:4587
Unknown Analyst
SBI Securities
Not Ranked
SBI Securities
¥3,600→¥3,200
Buy
91.73%
Upside
Reiterated
03/02/26
SBI Securities Reaffirms Their Buy Rating on Peptidream (PPTDF)
Nomura Analyst forecast on JP:4587
Unknown Analyst
Nomura
Not Ranked
Nomura
¥2,700
Buy
61.77%
Upside
Reiterated
02/17/26
Nomura Sticks to Their Buy Rating for Peptidream (PPTDF)
Goldman Sachs Analyst forecast on JP:4587
Akinori Ueda
Goldman Sachs
Goldman Sachs
¥3,000→¥2,750
Buy
64.77%
Upside
Reiterated
02/17/26
Goldman Sachs Reaffirms Their Buy Rating on Peptidream (PPTDF)
SMBC Nikko Analyst forecast on JP:4587
Unknown Analyst
SMBC Nikko
Not Ranked
SMBC Nikko
¥2,700
Buy
61.77%
Upside
Reiterated
12/10/25
Mizuho Securities Analyst forecast on JP:4587
Unknown Analyst
Mizuho Securities
Not Ranked
Mizuho Securities
¥4,400
Buy
163.63%
Upside
Reiterated
12/09/25
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Citi Analyst forecast on JP:4587
Hidemaru Yamaguchi
Citi
Citi
¥1,600
Hold
-4.13%
Downside
Downgraded
03/12/26
Citi Remains a Hold on Peptidream (PPTDF)
SBI Securities Analyst forecast on JP:4587
Unknown Analyst
SBI Securities
Not Ranked
SBI Securities
¥3,600→¥3,200
Buy
91.73%
Upside
Reiterated
03/02/26
SBI Securities Reaffirms Their Buy Rating on Peptidream (PPTDF)
Nomura Analyst forecast on JP:4587
Unknown Analyst
Nomura
Not Ranked
Nomura
¥2,700
Buy
61.77%
Upside
Reiterated
02/17/26
Nomura Sticks to Their Buy Rating for Peptidream (PPTDF)
Goldman Sachs Analyst forecast on JP:4587
Akinori Ueda
Goldman Sachs
Goldman Sachs
¥3,000→¥2,750
Buy
64.77%
Upside
Reiterated
02/17/26
Goldman Sachs Reaffirms Their Buy Rating on Peptidream (PPTDF)
SMBC Nikko Analyst forecast on JP:4587
Unknown Analyst
SMBC Nikko
Not Ranked
SMBC Nikko
¥2,700
Buy
61.77%
Upside
Reiterated
12/10/25
Mizuho Securities Analyst forecast on JP:4587
Unknown Analyst
Mizuho Securities
Not Ranked
Mizuho Securities
¥4,400
Buy
163.63%
Upside
Reiterated
12/09/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Peptidream

3 Months
Akinori UedaGoldman Sachs
Success Rate
0/4 ratings generated profit
0%
Average Return
-18.43%
Copying Akinori Ueda's trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -18.43% per trade.
1 Year
Akinori UedaGoldman Sachs
Success Rate
0/4 ratings generated profit
0%
Average Return
-42.77%
Copying Akinori Ueda's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -42.77% per trade.
2 Years
Akinori UedaGoldman Sachs
Success Rate
0/4 ratings generated profit
0%
Average Return
-49.13%
Copying Akinori Ueda's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -49.13% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

4587 Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
5
3
3
1
0
Buy
1
0
0
0
0
Hold
0
1
1
1
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
6
4
4
2
0
In the current month, 4587 has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 4587 average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.

4587 Stock Forecast FAQ

What is JP:4587’s average 12-month price target, according to analysts?
Currently, no data Available
What is JP:4587’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for JP:4587, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Peptidream Inc. a Buy, Sell or Hold?
      Currently, no data Available
      What is Peptidream Inc.’s share price target?
      Currently, no data Available
      What do analysts say about Peptidream Inc.?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Peptidream Inc.?
      To buy shares of JP:4587, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.